MedPath

FUJIFILM TOYAMA CHEMICAL CO., LTD.

FUJIFILM TOYAMA CHEMICAL CO., LTD. logo
🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of FF-31501 in Meniscus Tear Patients

Phase 3
Active, not recruiting
Conditions
Meniscus Injury
Interventions
Biological: human autologous synovial stem cells
First Posted Date
2023-03-21
Last Posted Date
2024-02-02
Lead Sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Target Recruit Count
18
Registration Number
NCT05777967
Locations
🇯🇵

Tokyo Medical and Dental University Hospital, Tokyo, Japan

🇯🇵

Mie Prefectural General Medical Center, Mie, Japan

🇯🇵

Medical corporation keimeikai Juko Osu hospital, Aichi, Japan

and more 1 locations

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Phase 2
Completed
Conditions
Mild Cognitive Impairment
Interventions
Drug: Placebo
First Posted Date
2019-12-09
Last Posted Date
2023-10-23
Lead Sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Target Recruit Count
221
Registration Number
NCT04191486
Locations
🇬🇧

Imperial College Healthcare NHS Trust, London, United Kingdom

🇨🇿

CLINTRIAL, s.r.o., Prague, Czechia

🇩🇪

Universitätsklinikum Magdeburg Institut für Kognitive Neurologie und Demenzforschung, Magdeburg, Germany

and more 34 locations

PK Study of T-817 in Subjects With Hepatic Impairment

Phase 1
Completed
Conditions
Healthy
Hepatic Impairment
Interventions
First Posted Date
2016-02-26
Last Posted Date
2017-11-24
Lead Sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Target Recruit Count
36
Registration Number
NCT02693197
Locations
🇺🇸

Orlando Clinical Research Center, Orlando, Florida, United States

🇺🇸

University of Miami, Miami, Florida, United States

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: T-817MA-L
Drug: Placebo
Drug: T-817MA-H
First Posted Date
2014-03-06
Last Posted Date
2019-02-26
Lead Sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Target Recruit Count
482
Registration Number
NCT02079909
Locations
🇺🇸

Hospital at the University of Pennsylvania, Penn Memory Center, Philadelphia, Pennsylvania, United States

🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

🇺🇸

University of Pittsburgh, Alzheimer Disease Research Center, Pittsburgh, Pennsylvania, United States

and more 47 locations

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
First Posted Date
2008-04-22
Last Posted Date
2013-11-05
Lead Sponsor
FUJIFILM Toyama Chemical Co., Ltd.
Target Recruit Count
373
Registration Number
NCT00663936
Locations
🇺🇸

Geriatric and Adult Psychiatry, LCC, Hamden, Connecticut, United States

🇺🇸

NeuroPsychiatric Center of the Palm Beaches, Boynton Beach, Florida, United States

🇺🇸

Banner Alzheimer's Institute, Phoenix, Arizona, United States

and more 32 locations
© Copyright 2025. All Rights Reserved by MedPath